- Home
- PRP (Platelet-Rich Plasma) Injection Therapy — A Natural, Minimally Invasive Option for Pain and Injury Recovery
Soft-tissue injuries involving tendons, ligaments or muscles can lead to prolonged discomfort, stiffness and limitations in daily activity. When symptoms continue despite rest, medication or physiotherapy, treatment options that assist the body’s own healing processes may be considered. PRP injection therapy provides a minimally invasive approach for selected tendon, muscle and ligament injuries, helping to ease pain and support tissue repair without the need for surgery.
What is PRP injection therapy?
PRP (Platelet-Rich Plasma) injection therapy is a treatment that uses a concentrated suspension of platelets obtained from a patient’s own blood. Platelets are cellular components that contain growth factors and bioactive proteins involved in the body’s natural repair processes.
To create PRP, a small blood sample is collected and processed using a centrifuge. This separates the blood into layers, allowing the platelet-rich portion to be isolated. The result is a plasma solution with a platelet concentration significantly higher than that found in whole blood.
This concentrated formulation serves as a biologically active preparation used in musculoskeletal and regenerative medicine. It contains an increased level of the growth factors typically released during tissue healing, but in a more focused and controlled form. PRP is purely autologous, meaning no external substances are added; the final product consists solely of the patient’s own plasma and concentrated platelets.
How does PRP injection therapy work?
PRP injection therapy functions by concentrating a patient’s platelets and delivering them directly into tissues that may benefit from additional biological support. The process involves several controlled stages to ensure accuracy, sterility and appropriate platelet concentration.
- Blood collection — a small volume of blood is drawn from the patient in a sterile manner.
- Centrifugation and separation — the collected sample is placed in a centrifuge, where spinning separates the blood into layers, allowing the platelet-rich portion to be isolated.
- Preparation of the PRP sample — the concentrated platelet suspension is collected into a sterile syringe without the addition of external agents.
- Image-guided administration — ultrasound guidance is used to inject the PRP into the targeted tendon, ligament, muscle or joint.
- Post-injection biological response — the delivered platelets release growth factors that participate in tissue-repair pathways over the following weeks.
What conditions can PRP injection therapy treat?
PRP injection therapy is used in musculoskeletal medicine for conditions where soft-tissue structures exhibit irritation, delayed healing or early degenerative changes. It is commonly considered when symptoms persist despite rest, activity modification or rehabilitation.
- Tendinopathy — chronic irritation involving tendons such as lateral epicondylitis, medial epicondylitis, patellar tendinopathy and Achilles tendinopathy.
- Ligament strains — low-grade ligament injuries where healing is slow or incomplete.
- Muscle injuries — acute or recurrent muscle strains that require biological support during recovery.
- Enthesopathy — irritation at tendon or ligament attachment points, particularly in weight-bearing or high-use regions.
- Early joint degeneration — mild to moderate degenerative changes, particularly in the knee, where biological stimulation may support symptomatic relief.
- Overuse-related conditions — injuries associated with repetitive loading, sports participation or occupational strain.
What are the benefits of PRP injection therapy?
PRP injection therapy offers several advantages within musculoskeletal and regenerative medicine, particularly for soft-tissue structures that heal slowly or demonstrate persistent irritation. The benefits relate to the biological characteristics of platelets and the targeted manner in which they are delivered.
- Autologous preparation — the PRP formulation is derived entirely from the patient’s own blood, which minimised the likelihood of adverse immune reactions.
- Concentrated biological activity — the higher platelet concentration provides an increased level of growth factors compared with whole blood, offering additional support to tissues undergoing repair.
- Targeted delivery — image guidance enables precise injection into specific tendons, ligaments, muscles or joint compartments, which helps ensure that the biological stimulus reaches the intended site.
- Minimally invasive approach — PRP serves as an option for conditions that do not require surgical repair but have not responded adequately to conservative measures.
- Compatibility with rehabilitation — PRP can be integrated into physiotherapy or loading programmes, supporting tissue recovery while structured rehabilitation continues.
- Low systemic impact — because the treatment acts locally at the injection site, systemic effects are minimal.
What to expect during PRP injection therapy?
At Total Pain Specialist, PRP injections are performed by an anaesthetist trained in image-guided musculoskeletal procedures. The treatment is carried out in a controlled outpatient setting, following sterile technique and established pain-management protocols. Although specific details vary depending on the area being treated, the overall experience remains consistent.
- Procedure environment — injections are performed in a treatment room equipped for sterile preparation and ultrasound-guided interventions.
- Discomfort levels — mild to moderate pressure or short-lived discomfort can occur during the injection, especially when treating sensitive soft-tissue regions. Local anaesthetic may be used depending on the site.
- Duration — the process includes a brief preparation phase followed by a short injection session.
- Immediate post-injection response — temporary soreness, localised stiffness or a feeling of fullness is expected over the first few days as the biological response begins.
- Activity guidance — routine daily activities can generally be resumed soon after the procedure, while high-intensity loading of the treated structure is restricted for a period determined by the clinician.
- Early recovery period — post-injection discomfort may continue for several days before improving. Symptom changes typically progress gradually in the weeks that follow as tissue-repair processes are activated.
Risks and considerations of PRP injection therapy
PRP injection therapy is generally considered safe because it uses an autologous preparation derived from the patient’s own blood. Even so, it remains a medical procedure and certain risks and considerations must be acknowledged before treatment.
- Post-injection discomfort — transient soreness, stiffness or a dull ache is common in the first few days as the injected area responds to the concentrated platelet formulation.
- Localised swelling — mild swelling may occur around the injection site and usually settles without intervention.
- Bleeding or bruising — minor bruising can develop at the point of needle entry, particularly in areas with limited soft-tissue coverage.
- Infection risk — although uncommon, any procedure involving needle insertion carries a small risk of infection. Strict sterile technique is used to minimise this.
- Delayed onset of improvement — biological treatments such as PRP often require several weeks before changes in symptoms are noticeable, as the effects depend on tissue-repair processes rather than immediate analgesia.
- Medication considerations — anticoagulants, antiplatelet agents or recent steroid injections may influence timing or suitability and are assessed during clinical evaluation.
PRP Injection Therapy vs Other Treatment Options
PRP injection therapy is one of several approaches used to manage soft-tissue irritation, overuse injuries and early degenerative changes. Its role is determined by the underlying pathology, symptom duration and response to earlier treatments.
- Physiotherapy and structured rehabilitation — loading programmes remain the foundation of treatment for tendon and ligament conditions. PRP does not replace rehabilitation; instead, it may be considered when progress has plateaued despite appropriate therapy.
- Oral medication — analgesics and anti-inflammatory agents provide symptom relief but do not directly influence tissue-repair mechanisms. PRP differs by delivering concentrated platelets and growth factors to the affected area.
- Steroid injections — corticosteroids can offer short-term reduction in inflammation, particularly in acute flare-ups. Their effect is temporary and does not support long-term tissue healing. PRP acts through biological stimulation rather than suppression of inflammation.
- Hyaluronic acid injections — used primarily for joint-related symptoms, hyaluronic acid supplements joint lubrication and may reduce mechanical discomfort. PRP is considered when a biological healing stimulus is required, especially in soft-tissue structures.
- Shockwave therapy — this modality stimulates tissue response through mechanical energy rather than biological concentration. It may be used alone or alongside PRP, depending on clinical judgement.
- Surgical intervention — procedures such as tendon repair or arthroscopy are reserved for situations where structural damage is significant or non-operative options have been exhausted. PRP is positioned earlier in the treatment pathway as a minimally invasive option.
Who is not suitable for PRP injection therapy?
PRP injection therapy is generally well tolerated, but certain medical conditions, medications and clinical circumstances can limit its suitability. A proper assessment is required to ensure the treatment is safe and appropriate for each patient.
- Active infection — local or systemic infection must be treated before PRP can be considered.
- Uncontrolled chronic illness — poorly controlled diabetes, cardiovascular instability or other significant medical issues may increase risk and affect safety.
- Blood or platelet disorders — severe anaemia, thrombocytopenia or clotting abnormalities can interfere with PRP preparation and effectiveness.
- Anticoagulant or antiplatelet therapy — medications that alter clotting or platelet function may reduce PRP quality or affect decision-making around timing.
- Recent corticosteroid exposure — high-dose or recent steroid injections can influence platelet activity and may require postponement of PRP.
- Active malignancy — PRP is generally avoided in patients with active cancer unless specifically cleared for musculoskeletal management.
- Pregnancy — PRP is usually deferred during pregnancy unless there is a clear clinical indication and obstetric approval.
- Severe structural damage — advanced degenerative disease or complete tendon rupture may not respond to PRP and may require alternative treatment pathways.
Summary
PRP injection therapy provides a biologically focused approach for managing tendon irritation, ligament strain, muscle injuries and early degenerative changes. By concentrating a patient’s own platelets and delivering them directly into affected tissues, the treatment supports repair processes that may be slow or incomplete with conservative care alone. It is performed in a controlled outpatient environment, guided by ultrasound and generally involves minimal downtime. While post-injection soreness is expected, the overall safety profile is favourable and the treatment can be integrated with rehabilitation programmes to optimise outcomes. PRP is typically considered when symptoms persist despite rest, physiotherapy or activity modification and when surgical intervention is not indicated.
If persistent pain is limiting daily function or hindering recovery, a clinical assessment can help determine whether PRP injection therapy is an appropriate option. Schedule an appointment with Total Pain Specialist to discuss the most suitable approach for your condition and treatment goals.
Frequently asked questions
Most patients experience mild pressure or brief discomfort during the injection. Temporary soreness is expected for a few days as the tissue responds to the platelet concentrate.
Improvement is gradual and usually develops over 4–12 weeks. The response depends on the condition treated and the tissue’s natural healing rate.
Some conditions improve after a single session, while others may need a series of injections. The treatment plan is based on clinical assessment and imaging findings.
PRP is considered safe because it uses the patient’s own blood. Side effects are usually limited to temporary soreness, swelling or bruising at the injection site.
PRP is often used for early knee joint degeneration and chronic soft-tissue irritation around the knee. Suitability depends on the degree of degeneration and clinical examination.
Routine daily activities can usually be resumed shortly after the procedure. Strenuous exercise or heavy loading is restricted for a period determined by the clinician.
The entire visit typically lasts 30–60 minutes, including blood collection, processing and ultrasound-guided injection.
Steroids reduce inflammation and provide short-term relief, while PRP delivers concentrated platelets that support tissue repair over a longer period.
Coverage varies by insurer and depends on the diagnosis. Patients are advised to check their policy or consult the clinic for clarification.
Patients may be asked to avoid anti-inflammatory medication before the procedure and maintain good hydration. Specific instructions are provided during consultation.
Total Pain Specialist